LRP1 and Alzheimer disease: LRP1 has received considerable attention as a therapeutic target of AD, as preclinical studies indicated that LRP1 largely contributes to the pathogenesis of AD by modulating Aβ clearance as well as via an Aβ-independent mechanism6,7.